ResearcherGradalis (United States)Active in the last 2 years
Donald Rao
Matched on OpenAlex author ID A5113544358, A5113599821. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Smart exosomes enhance PDAC targeted therapy. Co-author DOI 10.1016/j.jconrel.2024.02.037↗
- KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex. Co-author DOI 10.1371/journal.pone.0193644↗
- Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform. Co-author DOI 10.1038/cgt.2013.84↗
- PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. First author DOI 10.1371/journal.pone.0040452↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- John J. Nemunaitis · 4 shared papers, 2012–2024 · strength 0.35
- Paper Smart exosomes enhance PDAC targeted therapy. DOI 10.1016/j.jconrel.2024.02.037↗
- Paper KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS l… DOI 10.1371/journal.pone.0193644↗
- Paper Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctio… DOI 10.1038/cgt.2013.84↗
- Francis Charles Brunicardi · 4 shared papers, 2012–2024 · strength 0.35
- Paper Smart exosomes enhance PDAC targeted therapy. DOI 10.1016/j.jconrel.2024.02.037↗
- Paper KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS l… DOI 10.1371/journal.pone.0193644↗
- Paper Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctio… DOI 10.1038/cgt.2013.84↗
- Shi‐He Liu · 2 shared papers, 2012–2024 · strength 0.23
- Jingyuan Liu · 1 shared paper, 2024 · strength 0.20
- Justin F. Creeden · 1 shared paper, 2024 · strength 0.20
- Guisheng Zhou · 2 shared papers, 2012–2014 · strength 0.06
- Paper Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctio… DOI 10.1038/cgt.2013.84↗
- Paper PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference plat… DOI 10.1371/journal.pone.0040452↗
- James X. Wu · 1 shared paper, 2014 · strength 0.04
- William E. Fisher · 1 shared paper, 2012 · strength 0.03
- Marie‐Claude Gingras · 1 shared paper, 2012 · strength 0.03
- David W. Dawson · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.